Smith & Nephew plc (SNNUF)
OTCMKTS · Delayed Price · Currency is USD
18.20
0.00 (0.00%)
Sep 11, 2025, 8:00 PM EDT
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of $16.53 billion as of September 12, 2025. Its market cap has increased by 23.86% in one year.
Market Cap
16.53B
Enterprise Value
19.27B
Revenue
5.94B
Ranking
n/a
PE Ratio
33.66
Stock Price
$18.20
Market Cap Chart
Since December 31, 1985, Smith & Nephew's market cap has increased from 1.18B to 16.53B, an increase of 1,294.93%. That is a compound annual growth rate of 6.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 16.53B | 52.69% |
| Dec 31, 2024 | 10.82B | -9.46% |
| Dec 29, 2023 | 11.95B | 2.84% |
| Dec 30, 2022 | 11.62B | -24.46% |
| Dec 31, 2021 | 15.39B | -14.72% |
| Dec 31, 2020 | 18.04B | -14.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 739.21M |
| Elite Pharmaceuticals | 737.49M |
| Glass House Brands | 577.09M |
| Northwest Biotherapeutics | 376.88M |
| CytoDyn | 367.97M |
| American Oncology Network | 353.19M |